Gunderson advises iPierian in sale to Bristol-Myers Squibb
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP represented South San Francisco-based biotechnology company iPierian Inc. in its $175 million sale to Bristol-Myers Squibb Co., a deal announced April 29.
The cash deal also includes provisions for up to an additional $550 million if certain regulatory milestones are met, along w...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In